# Olanzapine Apotex 5 mg · 5.0000 mg · Orodispersible tablet · 56



## Belgium

- **FAMHP** — [be.dose-10060.org](https://be.dose-10060.org)

## Codes

- **be-cti-extended** — `375207-01`
- **be-cnk** — `2841963`
- **be-authorisation** — `EU/1/10/635/009`
- **eu-number** — `EU/1/10/635/009`

## Status

- **amp_status** — AUTHORIZED
- **ampp_status** — AUTHORIZED
- **commercialised_now** — False
- **lifecycle** — current
- **period_from** — 2010-06-10
- **supply_problem_now** — False
- **read** — 2026-11-15T03:58:09Z

## Holder

- Apotex Europe

## Proof

Record be:presentation:cti:375207-01 version 1, signed ES256 under dosidal-record-1.9dbf5d53.

## Related records in other markets

- [Olanzapine Apotex](https://dosidal.ai/pack/pl/104570) — PL — same product (EU central number)
- [Olanzapin Apotex 5 mg orodispergovateľné tablety](https://dosidal.ai/pack/sk/20978) — SK — same product (EU central number)

A link shows how two records are related. It does not say one product can be used in place of another.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
